BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6758923)

  • 1. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans.
    Boonchird C; Flegel TW
    Can J Microbiol; 1982 Nov; 28(11):1235-41. PubMed ID: 6758923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX; Bobek LA
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of phenothiazines against medically important yeasts.
    Eilam Y; Polacheck I; Ben-Gigi G; Chernichovsky D
    Antimicrob Agents Chemother; 1987 May; 31(5):834-6. PubMed ID: 3300543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
    Faria NC; Kim JH; Gonçalves LA; Martins Mde L; Chan KL; Campbell BC
    Lett Appl Microbiol; 2011 May; 52(5):506-13. PubMed ID: 21332761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal effects of vitamin K3 on Cryptococcus neoformans and Candida albicans.
    Jen TM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):250-2. PubMed ID: 6754288
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoxin D inhibits growth of zoopathogenic fungi.
    Becker JM; Covert NL; Shenbagamurthi P; Steinfeld AS; Naider F
    Antimicrob Agents Chemother; 1983 Jun; 23(6):926-9. PubMed ID: 6351734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of fluconazole, a novel bistriazole antifungal agent].
    Yamaguchi H; Uchida K; Kawasaki K; Matsunaga T
    Jpn J Antibiot; 1989 Jan; 42(1):1-16. PubMed ID: 2540356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
    Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
    Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity of eugenol analogues. Influence of different substituents and studies on mechanism of action.
    Carrasco H; Raimondi M; Svetaz L; Di Liberto M; Rodriguez MV; Espinoza L; Madrid A; Zacchino S
    Molecules; 2012 Jan; 17(1):1002-24. PubMed ID: 22262200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization and Antifungal Evaluation of Novel Thiochromanone Derivatives Containing Indole Skeleton.
    Han XY; Zhong YF; Li SB; Liang GC; Zhou G; Wang XK; Chen BH; Song YL
    Chem Pharm Bull (Tokyo); 2016 Sep; 64(9):1411-6. PubMed ID: 27373770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans.
    Tsai H; Bobek LA
    Biochim Biophys Acta; 1997 Oct; 1336(3):367-9. PubMed ID: 9367163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.